Cargando…

Expression of the SART‐1 Antigens in Uterine Cancers

We recently reported that the SART‐1 gene, encoding the SART‐1(259) tumor antigen which is recognized by HLA‐A26‐restricted cytotoxic T lymphocytes (CTLs), is expressed in the cytosol of squamous cell carcinomas and adenocarcinomas. The present study deals with the expression of SART‐1(259) and SART...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsumoto, Hajime, Shichijo, Shigeki, Kawano, Kouichiro, Nishida, Takashi, Sakamoto, Masaru, Itoh, Kyogo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1998
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921731/ https://www.ncbi.nlm.nih.gov/pubmed/10081490 http://dx.doi.org/10.1111/j.1349-7006.1998.tb00526.x

Ejemplares similares

Expression of Tumor‐rejection Antigens in Gynecologic Cancers
por: Tanaka, Shoko, et al.
Publicado: (2000)

Sequence Analysis of Genes Encoding Rodent Homologues of the Human Tumor‐rejection Antigen SART‐1
por: Gotoh, Masashi, et al.
Publicado: (1998)

Expression of SART3 antigen and induction of CTLs by SART3-derived peptides in breast cancer patients
por: Suefuji, Y, et al.
Publicado: (2001)

Expression of SART3 Tumor‐rejection Antigen in Gastric Cancers
por: Niiya, Fumihiko, et al.
Publicado: (2000)

Mouse Homologue of the Human SART3 Gene Encoding Tumor‐rejection Antigen
por: Harada, Kenji, et al.
Publicado: (2000)

Cytokines Required for Induction of Histocompatibility Leukocyte Antigen‐class I‐restricted and Tumor‐specific Cytotoxic T Lymphocytes by a SART1‐derived Peptide
por: Matsunaga, Kazuko, et al.
Publicado: (1999)

Identification of B cell epitopes reactive to human papillomavirus type-16L1- derived peptides
por: Fukui, Akimasa, et al.
Publicado: (2012)

Immunological evaluation of peptide vaccination for cancer patients with the HLA-A26 allele
por: Sakamoto, Shinjiro, et al.
Publicado: (2015)

Antitumor activity of antibody against cytotoxic T lymphocyte epitope peptide of lymphocyte‐specific protein tyrosine kinase
por: Matsueda, Satoko, et al.
Publicado: (2018)

Plasma Levels of High-Mobility Group Box 1 during Peptide Vaccination in Patients with Recurrent Ovarian Cancer
por: Waki, Kayoko, et al.
Publicado: (2017)

Immunological evaluation of peptide vaccination for cancer patients with the HLA ‐A11(+) or ‐A33(+) allele
por: Sakamoto, Shinjiro, et al.
Publicado: (2017)

Identification of biomarkers for personalized peptide vaccination in 2,588 cancer patients
por: Suekane, Shigetaka, et al.
Publicado: (2020)

Plasma level of prostate related-antigen peptide-reactive IgG is a prognostic factor of patients with breast cancer treated with personalized peptide vaccines
por: Saku, Shuko, et al.
Publicado: (2021)

Expression of MAGE‐1 Gene by Esophageal Carcinomas
por: Toh, Yuji, et al.
Publicado: (1995)

Identification of Cyclophilin B‐derived Peptides Capable of Inducing Histocompatibility Leukocyte Antigen‐A2‐restricted and Tumor‐specific Cytotoxic T Lymphocytes
por: Tamura, Mayumi, et al.
Publicado: (2001)

Elevation of Serum MAGE‐4 Protein Levels and Prediction of Hepatocellular Carcinogenesis in Patients with Liver Cirrhosis
por: Yutani, Shigeru, et al.
Publicado: (2002)

Identification of novel Lck‐derived T helper epitope long peptides applicable for HLA‐A2(+) cancer patients as cancer vaccine
por: Matsueda, Satoko, et al.
Publicado: (2015)

A Gene Encoding Antigenic Peptides of Human Squamous Cell Carcinoma Recognized by Cytotoxic T Lymphocytes
por: Shichijo, Shigeki, et al.
Publicado: (1998)

Effects of the α(1)-adrenoceptor agonist phenylephrine on SART stress-induced orthostatic hypotension in rats
por: Funakami, Yoshinori, et al.
Publicado: (2010)

Personalized Kampo Medicine Facilitated Both Cytotoxic T Lymphocyte Response and Clinical Benefits Induced by Personalized Peptide Vaccination for Advanced Esophageal Cancer
por: Muroya, Daisuke, et al.
Publicado: (2016)

Personalized peptide vaccination for cervical cancer patients who have received prior platinum-based chemotherapy
por: Kawano, Kouichiro, et al.
Publicado: (2015)

Induction of MAGE Genes in Lymphoid Cells by the Demethylating Agent 5‐Aza‐2′‐deoxycytidine
por: Shichijo, Shigeki, et al.
Publicado: (1996)

Survival analysis of multiple peptide vaccination for the selection of correlated peptides in urological cancers
por: Noguchi, Masanori, et al.
Publicado: (2018)

Detection of MAGE‐4 Protein in the Sera of Patients with Hepatitis‐C Virus‐associated Hepatocellular Carcinoma and Liver Cirrhosis
por: Tsuzurahara, Shin‐ichi, et al.
Publicado: (1997)

SART-Type Image Reconstruction from Overlapped Projections
por: Yu, Hengyong, et al.
Publicado: (2011)

A randomized phase II trial of personalized peptide vaccine with low dose cyclophosphamide in biliary tract cancer
por: Shirahama, Takahisa, et al.
Publicado: (2017)

Detection of MAGE‐4 Protein in Sera of Lung Cancer Patients
por: Shichijo, Shigeki, et al.
Publicado: (1997)

The ribonucleotidyl transferase USIP-1 acts with SART3 to promote U6 snRNA recycling
por: Rüegger, Stefan, et al.
Publicado: (2015)

PERSPECTIVES OF THE EM-SART: INTERVIEWS WITH ADULT PROTECTIVE SERVICES CLIENTS
por: Burnett, Jason, et al.
Publicado: (2022)

Serine Proteinase Inhibitor 9 Can Be Recognized by Cytotoxic T Lymphocytes of Epithelial Cancer Patients
por: Tanaka, Koji, et al.
Publicado: (2002)

Investigation of factors associated with reduced clinical benefits of personalized peptide vaccination for pancreatic cancer
por: Uchino, Yoshihiro, et al.
Publicado: (2021)

Early phase II study of mixed 19‐peptide vaccine monotherapy for refractory triple‐negative breast cancer
por: Toh, Uhi, et al.
Publicado: (2020)

Phase II study of personalized peptide vaccination for refractory bone and soft tissue sarcoma patients
por: Takahashi, Ryuji, et al.
Publicado: (2013)

Phase II Study of Personalized Peptide Vaccination with Both a Hepatitis C Virus-Derived Peptide and Peptides from Tumor-Associated Antigens for the Treatment of HCV-Positive Advanced Hepatocellular Carcinoma Patients
por: Yutani, Shigeru, et al.
Publicado: (2015)

Tip110/SART3 regulates IL-8 expression and predicts the clinical outcomes in melanoma
por: Timani, Khalid Amine, et al.
Publicado: (2018)

Expression of Interferon Effector Gene SART1 Correlates with Interferon Treatment Response against Hepatitis B Infection
por: Li, Yong, et al.
Publicado: (2016)

Enhancing SART Validity by Statistically Controlling Speed-Accuracy Trade-Offs
por: Seli, Paul, et al.
Publicado: (2013)

RNA-splicing factor SART3 regulates translesion DNA synthesis
por: Huang, Min, et al.
Publicado: (2018)

SART and Individual Trial Mistake Thresholds: Predictive Model for Mobility Decline
por: Rizzo, Rossella, et al.
Publicado: (2021)

sart-3 functions to regulate germline sex determination in C. elegans .
por: Furuta, Tokiko, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ql13m6aiq5uthsjps1bfj3mf8i